Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia

Journal of Alzheimer's Disease

Volumn 33, Issue 1, 2013, Pages 45-53

  Olsson, Bob ^a   Hertze, Joakim ^b   Lautner, Ronald ^a   Zetterberg, Henrik ^a   Nägga, Katarina ^b   Höglund, Kina ^c   Basun, Hans ^d   Annas, Peter ^c   Lannfelt, Lars ^d   Andreasen, Niels ^e   Minthon, Lennart ^b   Blennow, Kaj ^a   Hansson, Oskar ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; biomarker; cerebrospinal fluid; dementia; microglia; vascular dementia

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROGLIA; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL;

EID: 84872435139     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120787     Document Type: Article

References (44)

1. Sonnen JA, Montine KS, Quinn JF, Kaye JA, Breitner JC, Montine TJ (2008) Biomarkers for cognitive impairment and dementia in elderly people. Lancet Neurol 7, 704-714. (Pubitemid 351965506)
2. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403. (Pubitemid 44108123)
3. Seshadri S,Wolf PA(2007) Lifetime risk of stroke and dementia: Current concepts, and estimates from the Framingham Study. Lancet Neurol 6, 1106-1114. (Pubitemid 350123607)
4. Wallin A, MilosV, Sjogren M, Pantoni L, Erkinjuntti T (2003) Classification and subtypes of vascular dementia. Int Psychogeriatr 15(Suppl 1), 27-37. (Pubitemid 37175164)
5. McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology 47, 425-432. (Pubitemid 26324038)
6. Stewart WF, Kawas C, Corrada M, Metter EJ (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626-632. (Pubitemid 27120096)
7. Szekely CA, Green RC, Breitner JC, Ostbye T, Beiser AS, Corrada MM, Dodge HH, Ganguli M, Kawas CH, Kuller LH, Psaty BM, Resnick SM, Wolf PA, Zonderman AB, Welsh-Bohmer KA, Zandi PP (2008) No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology 70, 2291-2298.
8. Lyketsos CG, Breitner JC, Green RC, Martin BK, Meinert C, Piantadosi S, Sabbagh M (2007) Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 68, 1800-1808. (Pubitemid 46791392)
9. Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, Ismail MS, Martin BK, Mullan MJ, Sabbagh M, Tariot PN (2011) Extended results of the Alzheimer's disease antiinflammatory prevention trial. Alzheimers Dement 7, 402-411.
10. Kravitz BA, Corrada MM, Kawas CH (2009) Elevated Creactive protein levels are associated with prevalent dementia in the oldest-old. Alzheimers Dement 5, 318-323.
11. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM (2004) Inflammatory proteins in plasma and the risk of dementia: The rotterdam study. Arch Neurol 61, 668-672. (Pubitemid 38637682)
12. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ (2002) Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52, 168-174. (Pubitemid 34810596)
13. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, MeradM(2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845.
14. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL3rd, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 86, 7611-7615. (Pubitemid 19254506)
15. Rogers J, Luber-Narod J, Styren SD, Civin WH (1988) Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol Aging 9, 339-349. (Pubitemid 19262065)
16. Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE (2012) ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335, 1503-1506.
17. Sun B, Zhou Y, Halabisky B, Lo I, Cho SH, Mueller-Steiner S, Devidze N, Wang X, Grubb A, Gan L (2008) Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease. Neuron 60, 247-257.
18. Zhu X, Su B, Wang X, Smith MA, Perry G (2007) Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 64, 2202-2210. (Pubitemid 47347959)
19. Norenberg W, Illes P, Gebicke-Haerter PJ (1994) Sodium channel in isolated human brain macrophages (microglia). Glia 10, 165-172.
20. Yin GN, Jeon H, Lee S, Lee HW, Cho JY, Suk K (2009) Role of soluble CD14 in cerebrospinal fluid as a regulator of glial functions. J Neurosci Res 87, 2578-2590.
21. Bonneh-Barkay D, Bissel SJ, Wang G, Fish KN, Nicholl GC, Darko SW, Medina-Flores R, Murphey-Corb M, Rajakumar PA, Nyaundi J, Mellors JW, Bowser R, Wiley CA (2008) YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am J Pathol 173, 130-143. (Pubitemid 351947961)
22. Rejman JJ, Hurley WL (1988) Isolation and characterization of a novel 39 kilodalton whey protein from bovine mammary secretions collected during the nonlactating period. Biochem Biophys Res Commun 150, 329-334. (Pubitemid 18036240)
23. Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268, 25803-25810. (Pubitemid 23358198)
24. Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM,Quinn JF, D'Angelo G, Malone JP,Townsend RR, Morris JC, Fagan AM, HoltzmanDM(2010) YKL-40: A novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry 68, 903-912.
25. Mattsson N, Tabatabaei S, Johansson P, Hansson O, Andreasson U, Mansson JE, Johansson JO, Olsson B, Wallin A, Svensson J, Blennow K, Zetterberg H (2011) Cerebrospinal fluid microglial markers in Alzheimer's disease: Elevated chitotriosidase activity but lack of diagnostic utility. Neuromolecular Med 13, 151-159.
26. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM (1988) The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 141, 547-552.
27. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A,Wood WI, Gurney AL, Godowski PJ (1998) Tolllike receptor-2 mediates lipopolysaccharide- induced cellular signalling. Nature 395, 284-288. (Pubitemid 28447554)
28. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282, 2085-2088. (Pubitemid 29001265)
29. Lee HK, Dunzendorfer S, Soldau K, Tobias PS (2006) Double-strandedRNA- mediated TLR3 activation is enhanced by CD14. Immunity 24, 153-163. (Pubitemid 43214585)
30. Baumann CL, Aspalter IM, Sharif O, Pichlmair A, Bluml S, Grebien F, Bruckner M, Pasierbek P, Aumayr K, Planyavsky M, Bennett KL, Colinge J, Knapp S, Superti-Furga G (2010) CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med 207, 2689-2701.
31. Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE (2010) Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the brain's inflammatory milieu. J Neurosci 30, 15369-15373.
32. Hertze J, Minthon L, Zetterberg H, Vanmechelen E, Blennow K, Hansson O (2010) Evaluation of CSF biomarkers as predictors of Alzheimer's disease: A clinical follow-up study of 4.7 years. J Alzheimers Dis 21, 111911-111928.
33. Association AP (1987) Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). 3rd Rev ed. American Psychiatric Publishing, Inc.
34. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
35. PetersenRC(2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183-194.
36. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, HofmanAet al. (1993)Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260. (Pubitemid 23060253)
37. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Desmond DW (2000) Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 59, 23-30. (Pubitemid 30479402)
38. McKeith IG, Perry EK, Perry RH (1999) Report of the second dementia with Lewy body international workshop: Diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 53, 902-905. (Pubitemid 29442100)
39. Blennow K, Zetterberg H, Minthon L, Lannfelt L, Strid S, Annas P, Basun H, Andreasen N(2007) Longitudinal stability of CSF biomarkers in Alzheimer's disease. Neurosci Lett 419, 18-22. (Pubitemid 46694097)
40. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th Edition ed. Washington, D.C.
41. Tibbling G, Link H, Ohman S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37, 385-390. (Pubitemid 8387871)
42. Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K (2005) Simultaneous measurement of betaamyloid( 1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem 51, 336-345. (Pubitemid 40175803)
43. Schuitemaker A, van der Doef TF, Boellaard R, van der Flier WM, Yaqub M, Windhorst AD, Barkhof F, Jonker C, Kloet RW, Lammertsma AA, Scheltens P, van Berckel BN (2012) Microglial activation in healthy aging. Neurobiol Aging 33, 1067-1072.
44. Cauwels A, Frei K, Sansano S, Fearns C, Ulevitch R, Zimmerli W, Landmann R (1999) The origin and function of solubleCD14in experimental bacterial meningitis. J Immunol 162, 4762-4772. (Pubitemid 29314878)